BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 35738680)

  • 41. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
    Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
    Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Matrix metalloproteinases in tumorigenesis: an evolving paradigm.
    Hua H; Li M; Luo T; Yin Y; Jiang Y
    Cell Mol Life Sci; 2011 Dec; 68(23):3853-68. PubMed ID: 21744247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of matrix metalloproteinases and histone deacetylase in oxidative stress-induced degradation of the endothelial glycocalyx.
    Ali MM; Mahmoud AM; Le Master E; Levitan I; Phillips SA
    Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H647-H663. PubMed ID: 30632766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of Matrix Metalloproteinases (MMPs) Expression in Periodontal Diseases.
    Liu N; Zhou B; Zhu G
    Med Sci Monit; 2016 Jun; 22():1936-8. PubMed ID: 27272560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression.
    Niland S; Riscanevo AX; Eble JA
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Missing the target: matrix metalloproteinase antitargets in inflammation and cancer.
    Dufour A; Overall CM
    Trends Pharmacol Sci; 2013 Apr; 34(4):233-42. PubMed ID: 23541335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases.
    de Bruyn M; Vandooren J; Ugarte-Berzal E; Arijs I; Vermeire S; Opdenakker G
    Crit Rev Biochem Mol Biol; 2016 Sep; 51(5):295-358. PubMed ID: 27362691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myocardial matrix metalloproteinase-2: inside out and upside down.
    DeCoux A; Lindsey ML; Villarreal F; Garcia RA; Schulz R
    J Mol Cell Cardiol; 2014 Dec; 77():64-72. PubMed ID: 25261607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Matrix Metalloproteinase-Responsive Drug Delivery Systems.
    Zhang C; Jiang G; Gao X
    Bioconjug Chem; 2023 Aug; 34(8):1349-1365. PubMed ID: 37533285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
    Chen Y; Peng W; Raffetto JD; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases.
    Lagente V; Boichot E
    J Mol Cell Cardiol; 2010 Mar; 48(3):440-4. PubMed ID: 19818795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma.
    Napoli S; Scuderi C; Gattuso G; Bella VD; Candido S; Basile MS; Libra M; Falzone L
    Cells; 2020 May; 9(5):. PubMed ID: 32392801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro dose-dependent effects of matrix metalloproteinases on ECM hydrogel biodegradation.
    Didwischus N; Guduru A; Badylak SF; Modo M
    Acta Biomater; 2024 Jan; 174():104-115. PubMed ID: 38081445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Matrix metalloproteinases: potential therapeutic target for diabetic neuropathic pain.
    Kuhad A; Singh P; Chopra K
    Expert Opin Ther Targets; 2015 Feb; 19(2):177-85. PubMed ID: 25243524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.
    Candelario-Jalil E; Yang Y; Rosenberg GA
    Neuroscience; 2009 Feb; 158(3):983-94. PubMed ID: 18621108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting Matrix Metalloproteinases for Diabetic Retinopathy: The Way Ahead?
    Solanki A; Bhatt LK; Johnston TP; Prabhavalkar KS
    Curr Protein Pept Sci; 2019; 20(4):324-333. PubMed ID: 30215334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.
    DeLeon-Pennell KY; Meschiari CA; Jung M; Lindsey ML
    Prog Mol Biol Transl Sci; 2017; 147():75-100. PubMed ID: 28413032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation and silencing of matrix metalloproteinases.
    Fu X; Parks WC; Heinecke JW
    Semin Cell Dev Biol; 2008 Feb; 19(1):2-13. PubMed ID: 17689277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of Matrix Metalloproteinases in Angiogenesis and Its Implications in Asthma.
    Bajbouj K; Ramakrishnan RK; Hamid Q
    J Immunol Res; 2021; 2021():6645072. PubMed ID: 33628848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Matrix Metalloproteases as Influencers of the Cells' Social Media.
    Young D; Das N; Anowai A; Dufour A
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31394726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.